Searchable abstracts of presentations at key conferences in endocrinology

ea0056p827 | Pituitary - Clinical | ECE2018

Benefits of pre-surgical treatment with somatostatin analogs in naive patients with acromegaly

Cornejo-Pareja Isabel M , Maraver-Selfa Silvia , Munoz-Garach Araceli , Gonzalez-Molero Inmaculada , Mancha-Doblas Isabel , Tinahones Francisco

Introduction: Somatostatin analogs (SS-analogs) are the treatment option when there is a persistent disease despite surgical intervention. They can be also recommended as a first line treatment if surgery is not appropriate (non-curative or contraindicated surgery).Objetive: To evaluate the effect of first-generation SS-analogs (lanreotide and octreotide) on tumour shrinkage and biochemical control in naive patients.Methods: We per...

ea0056p1144 | Thyroid cancer | ECE2018

Changing treatment trends with radioiodine in thyroid carcinoma at the beginning of 21st century in Castilla-La Mancha (Spain)

Delgado Manuel , Sastre Julia , Quiroga Ivan , Gonzalez Javier , Torres Belvis , Aznar Silvia , Alvarez Visitacion , Herranz Sandra , Moreno Jesus , Gomez Paz

Background and objective: The incidence of differentiated thyroid carcinoma (DTC) is increasing worldwide. Radioiodine (RAI) ablation is one of the main elements in the therapy of DTC after surgical removal of the gland. This study aims to compare the use of I131 in a Spanish Cohort of DTC before and after the American Thyroid Association (ATA) 2009 guidelines.Patients and methods: The Cadit-CAM study was designed to evaluate retrospectively characterist...

ea0056p1203 | Thyroid cancer | ECE2018

Comparative study about differences in staging and prognosis in patients affected or not of BRAF V600E mutation

Gonzalez Javier , Calderon Dulce Maria , Alramadan Mubarak , Perez Jose , Martin David , Acedo Raquel , Jimenez Fulgencio , Campos Yolanda

Introduction, material and methods: The BRAF isoform of RAF has been implicated in the pathogenesis of papillary thyroid cancer, but not of benign or follicular neoplasms. Also, BRAF mutations may confer a worse clinical prognosis than for papillary thyroid cancer without the BRAF mutation. Recurrence occurs more frequently when BRAF mutations are present. In addition, BRAF mutations are associated with extrathyroidal invasion, lymph node me...

ea0098c20 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Yttrium 90 transarterial radioembolization of neuroendocrine liver metastasis

Yuan Gavin , Petre Elena , Ziv Etay , Moussa Amgad , Gonzalez Aguirre Adrian , Latzman Jonathan , Reidy Diane , Raj Nitya , Alexander Erica

Background: To determine the safety and efficacy of Yttrium 90 (Y90) transarterial radioembolizations (TARE) for neuroendocrine liver metastasis (NLM) and elucidate factors that affect outcomes.Methods: Retrospective analysis of 39 patients with NLM in a single center who underwent 65 Y90 TAREs with glass or resin microspheres between April 2012 and December 2022. There were 17 male and 22 female with a mean age at time of treatment of 65.5 years (SD &pm...

ea0051oc7.7 | Oral Communications 7 | BSPED2017

Role of Degludec in improving diabetes outcomes in young people - An observational study from Young Diabetes Connections (YDC) Network, London

Nambisan Aparna K R , Fredriksen Samantha , Rowland Amy , Morrow Hannah , Castro-Gonzalez Marie , Ajzensztejn Michal , Hulse Tony , Lawrence Joanna , Shamekh Ahmed , Ford-Adams Martha , Chapman Simon

Introduction: YDC is a partnership of four hospital trusts;Kings College Hospital, Princess Royal University Hospital, Lewisham University Hospital and Evelina London Children’s Hospital,caring for a total of 492 children and young people with diabetes. Most young people are on conventional long acting insulin (Levemir and Glargine), but increasingly, poorly controlled patients (HbA1C>100 mmol/mol) with high admission rates are being switched to insulin Degludec due t...

ea0081p711 | Reproductive and Developmental Endocrinology | ECE2022

Demographic trends and morbidity in the basque country transgender population (2009-2020)

Gonzalez Fernandez Pedro , del Carmen Fernandez Lopez Maria , Ponce de Leon Saenz de Navarrete Susana , Bolado Maria Gema Grau , Luisa Guadilla Fernandez Maria , Rica Echevarria Itxaso

Introduction: The number of transgender men and women who seek gender-affirming therapy is rapidly increasing worldwide. It is still a population at high risk for several morbidities. The Basque Country Gender Identity Clinic was created in 2009 to centralize their medical care in the region.Aim: To determine the proportion of transgender individuals in the Basque Country, the prevalence of several morbidities in this transgender population, their evolut...

ea0081p756 | Thyroid | ECE2022

Radiofrequency and ethanol ablation for benign thyroid nodules: case series

Jimenez Torrecilla Pedro , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montalban Mendez Cristina , Zhao Montero Benitez Maria , del Val Zaballos Florentino , Gomez Garcia Ines

Introduction: Thyroid nodule is a frequent condition, being diagnosed in up to 70% of subjects who had undergone thyroid ultrasound. Around 90-95% of them became being benign and, if the do not cause compressive symptoms or esthetical problems, they do not need specific therapy, only clinical follow up. Traditionally, thyroidectomy has been the main therapeutic option in these cases. Radiofrequency and ethanol ablations are recently introduced non-invasive therapies that permi...

ea0090p619 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Pancreatic autoimmunity in the diagnosis of type 1 diabetes: usefulness of zinc transporter 8 and proposal for stepwise assessment

Rodriguez Escobedo Raul , Gonzalez Martinez Silvia , Alonso Felgueroso Carlos , Morales Sanchez Paula , Diaz Naya Lucia , Delgado Elias , Luis Menendez Torre Edelmiro

Introduction: Zinc transporter 8 (ZnT8) autoimmunity has been established as one of the markers for the diagnosis of type 1 diabetes (T1D) along with glutamate decarboxylase (GAD) and tyrosine phosphatase IA-2 (IA-2) antibodies. The aim of this study is to understand the status of pancreatic autoimmunity in the diagnosis of T1D, with special attention to the usefulness of ZnT8. In addition, as a second objective, we study the proposal to perform the assessment of pancreatic au...

ea0090ep256 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Influence of diabetes mellitus on changes in preperitoneal fat measured by nutritional ultrasound, in a cohort of patients who required intensive care unit (ICU) admittance due to severe covid-19 pneumonia, during a 6-month follow-up program

Simon Frapolli Victor Jose , Aguilar Isabel Vegas , Rosa Victoria Gonzalez , Sanchez Garcia Ana Maria , Tinahones Madueno Francisco Jose , Garcia Almeida Jose Manuel

Introduction and Objectives: Preperitoneal fat is an ectopic visceral adipose tissue with a significant proinflammatory metabolic impact. The objective of this study is to measure preperitoneal fat by nutritional ultrasound at discharge, 3 months and 6 months in a cohort of patients who required admission to the Intensive Care Unit (ICU) due to severe COVID-19 pneumonia, and to analyze the differences based on the presence or not of previous DM.Material ...

ea0090ep694 | Pituitary and Neuroendocrinology | ECE2023

Thyrotropin-secreting pituitary tumor: a rare entity

Torrecilla Pedro Jimenez , Gonzalez Lazaro Paloma , Moreno Tirado Antonio , Montero Benitez Maria Zhao , Lomas Meneses Amparo , Del Val Zaballos Florentino , Contreras Pascual Cristina

TSH-secreting pituitary adenomas are a rare cause of hyperthyroidism. The diagnosis should be considered in all hyperthyroid patients, especially those with a diffuse goiter and no extrathyroidal manifestations of Graves’ disease. Most TSH-secreting adenomas secrete only TSH. Most patients have the typical symptoms and signs ofhyperthyroidism (eg, palpitations, tremor, heat intolerance), but a few patients have mild or even no hyperthyroid symptoms. Other clinical feature...